Fibrocystic Disease (USA)

40 year old lady asymptomatic screening mammography. Microcalcifications were detected on the left breast. And as you can see, the microcalcifications were also detected in the turmoil study. If we compare the 2D and the Tomo, we can clearly detect it microcalcifications and the turmoil study. But still magnification views are needed for a better characterization of microcalcifications. You can see in this magnification of used very good quality in the evaluation of the microcalcifications. A biopsy was performed vacuum assisted biopsy and. The final result was fibrocystic disease. So in conclusion. You can say that magnification of use are. Still living for the characterization of Microcalcifications, although Tomo. Is also useful.

Screening 4 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 04_Screening_4, PID3636 * 1/1/2022 F PID3636 Series Navigator INSIGHT_2D Add Study PID3636 12/1/2021 (Study date) Current Current Current LMSCC INSIGHT_2D_RCC Viewing Favorite Layouts US MR DYN PC.MLOICC C.US | C ... MR.Dyna ... ReportFlow MR.Empty BASIC Printing Tools Findings MR 3:30 PM Clinical information 40-year-old female Asymptomatic Healthineers RCC LCC RMLO LMLO Slice 20 / 55 Slice 16 / 56 Slice 22 / 57 Slice thickness: 1.00 mm Slice thickness: 1.00 mm Slice thickness: 1.00 mm Slice thickness: 1.00 mm |Slice thickness: 1.00 mm 12/1/2021 (Study date): Current: LMSML C.CC LMSCC: Series Navigator Back [CTRL B US vacuum-assisted biopsy Specimen radiograph Specimen radi Pathology Fibrocystic disease SIEMENS Conclusion Although DBT is useful to evaluate microcalcifications, magnification views are still necessary. 3:31 PM Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. Healt